CME Program Detail...
Update on Glucose-Lowering Medications for Type 2 Diabetes
Date: Tue, Oct 29th, 2024
Time: 8:00 am - 9:00 am
Location: Online
Silvio E. Inzucchi, MD
Disclosures: Dr. Inzucchi is a Consultant, Lectures, Trial Publications Committee for Boehringer Ingelheim/Lilly, AstraZeneca; Trial Steering Committee, Consultant for Novo Nordisk; Consultant for Merck, Pfizer; On the Data Monitoring Board for Bayer. All relevant relationships have been mitigated.
Target Audience: physicians, fellows, residents, students, PAs, NPs
> Describe the pathophysiology of type 2 diabetes.
> List the major advantages and disadvantages of the most commonly prescribed glucose lowering drug categories for patients with type 2 diabetes.
> Develop rational therapeutic strategies for patients with type 2 diabetes at high cardiovascular risk.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.
Grand Rounds
Department: Medicine
Specialty: Internal Medicine
Subspecialty: Endocrinology, Diabetes and Metabolism
CME Credit Hours: 1.0
Event Sponsors:
NYPQ CME
